GUCY1A1
GUCY1A1geneGUCY1A1 CAD-associated variants impair nitric-oxide signaling in the endothelium, promoting dysfunction and atherothrombotic risk.
Pathway placement
Cascade stepEndothelial activation & erosion
Confidencemedium
RationaleGuanylate cyclase mediates endothelial NO signaling; CAD GWAS locus suggests endothelial dysfunction role.
Druggability
DruggableYes
Known drugs / candidates15
Small-molecule tractableYes
Antibody tractableNo
EnsemblENSG00000164116
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Human genetic evidence
0.695
Open Targets association (myocardial_infarction)
3
GWAS associations
Traits: myocardial infarction
Literature evidence(1)
- Interpreting coronary artery disease GWAS results: A functional genomics approach assessing biological significance.PloS one · 2022 · PMID 35192625 · doi